Initial Submission Instructions
To receive IRB review and approval, please follow the instructions below:
1. Complete the appropriate submission form (initial, continuation, modification).
2. Ensure the submission form has been signed.
3. Submit the completed form, along with all supporting documents via email to
RCOinfo@nyu.edu.
Supporting documents include: recruitment flyers, posters, scripts; questionnaires/surveys; interview scripts; informed consent documents; child assent forms; parental permission forms; and any other materials that subjects will see or scripts of anything that will be said to subjects. In addition, please remember to submit your CITI training completion certification.
4. The SUBJECT LINE of the email must read: “IRB submission – (last name)”.
5. You will receive an email confirming receipt of your submission, your assigned protocol number (which will remain the number for your research from start through completion of the research. Please keep this number handy for future reference for this specific research project), and whether the submission is complete.
6. The submission (if complete) will then be forwarded to the IRB for review.
7. You will be notified of the IRB’s review determinations via email.
8. If the IRB requires additional information or changes to your research please try to respond to the IRB within two weeks of receiving your notification. Please submit this information via RCOinfo@nyu.edu. The subject line should read: “resubmission – the “protocol number” and “your last name”.
Please note: You cannot begin your research, including recruitment, until you have received notification of final IRB approval.
Other Submission Instructions
ANY and ALL changes (modifications) to a previously approved research project, such as changes to the inclusion/exclusion criteria, study population, study procedures, addition or deletion of investigators, or revisions to the consent process/form must receive IRB review and approval before the changes may be implemented. Depending on the level of risk to the study subjects, changes may be reviewed through either an expedited or a full board review process.
If a modification appears to increase the risks to subjects to more than minimal risk as defined by the US federal regulations, the modification request will be placed on the next agenda for full committee review.